dopamine transporter And NotCarlo Rossi
List of bibliographic references
Number of relevant bibliographic references: 17.Ident. | Authors (with country if any) | Title |
---|---|---|
000156 | Michael A. Schwarzschild [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Danna Jennings [États-Unis] ; John Seibyl [États-Unis] ; Alberto Ascherio [États-Unis] | Serum urate and probability of dopaminergic deficit in early “Parkinson's disease” |
000519 | Y. K. Kim ; I-Y. Yoon ; J-M. Kim [Corée du Sud] ; S-H. Jeong ; K. W. Kim ; Y-K. Shin ; B. S. Kim ; S. E. Kim | The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder |
000784 | K. Ishibashi [Japon] ; K. Kanemaru [Japon] ; Y. Saito [Japon] ; S. Murayama [Japon] ; K. Oda [Japon] ; K. Ishiwata [Japon] ; H. Mizusawa [Japon] ; K. Ishii [Japon] | Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease |
000D52 | Chun-Hung Lin ; Jui-Yen Huang [Taïwan] ; Cheng-Hsin Ching ; Jih-Ing Chuang [Taïwan] | Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats |
000F61 | Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] | Role of DAT‐SPECT in the diagnostic work up of Parkinsonism |
001482 | J. Eerola [Finlande] ; P J Tienari [Finlande] ; S. Kaakkola [Finlande] ; P. Nikkinen ; J. Launes [Finlande] | How useful is [123I]β-CIT SPECT in clinical practice? |
001518 | K. Stiasny-Kolster ; Y. Doerr ; J. C. Mo Ller ; H. Ho Ffken ; T. M. Behr ; W. H. Oertel ; G. Mayer [Allemagne] | Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT |
001548 | J. Wang [République populaire de Chine] ; Y. Jiang [République populaire de Chine] ; X. Liu [République populaire de Chine] ; Z. Chen [République populaire de Chine] ; L. Yang [République populaire de Chine] ; C. Liu [République populaire de Chine] ; J. Xiang [République populaire de Chine] ; H. Su [République populaire de Chine] | 99mTc‐TRODAT‐1 SPECT study in early Parkinson's disease and essential tremor |
001713 | Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Role of dopamine transporter imaging in routine clinical practice |
001714 | Werner Poewe [Autriche] ; Christoph Scherfler [Autriche] | Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice |
001795 | Walter Pirker [Autriche] | Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? |
001904 | Y. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; C. Yoo [Corée du Sud] ; C. R. Lee [Corée du Sud] ; J. H. Lee [Corée du Sud] ; H. K. Kim [Corée du Sud] ; S. O. Yang [Corée du Sud] ; H. K. Chung [Corée du Sud] ; D. S. Lee [Corée du Sud] ; B. Jeon [Corée du Sud] | Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean? |
001908 | K. Marek [États-Unis] ; D. Jennings [États-Unis] ; J. Seibyl [États-Unis] | Do dopamine agonists or levodopa modify Parkinson's disease progression? |
001923 | Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
001990 | Juha O. Rinne [Finlande] ; Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande] | [18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease |
001991 | Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Torniainen [Finlande] ; Kyösti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande] | [123I]β‐CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients |
001B69 | Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
![]() | This area was generated with Dilib version V0.6.23. | ![]() |